Understand the source comparison
[SLU PP332 Peptide]: Mechanism Comparison
SLU PP332 ERRα agonist. Mitochondrial biogenesis Skeletal muscle, brown adipose tissue, cardiac muscle Increases oxidative capacity and fat oxidation without reducing ATP efficiency None. Does not affect satiety hormones or gastric emptying Best suited for non
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- SLU PP332
- ERRα agonist. Mitochondrial biogenesis
- Skeletal muscle, brown adipose tissue, cardiac muscle
- Increases oxidative capacity and fat oxidation without reducing ATP efficiency
- None. Does not affect satiety hormones or gastric emptying
- Best suited for non-appetite-mediated metabolic research; effects concentrate in oxidative tissues
- Semaglutide / Tirzepatide
- GLP-1 receptor agonist. Slows gastric emptying, reduces appetite signaling
- Hypothalamus, gastrointestinal tract, pancreas
- Reduces caloric intake through satiety signaling; secondary fat loss from caloric deficit
- Strong. Primary mechanism involves appetite suppression
- Proven fat loss mechanism in humans; requires dietary compliance for maximal effect
- 5-Amino-1MQ
- NNMT inhibitor. Increases NAD+ availability and AMPK activation
- Liver, adipose tissue, skeletal muscle
- Shifts metabolism toward fat oxidation; reduces de novo lipogenesis
- Minimal. Metabolic shift occurs without appetite changes
- Cellular metabolism modulator; effects are dose-dependent and require consistent administration
- Ipamorelin
- Growth hormone secretagogue. Increases endogenous GH release
- Pituitary gland, adipose tissue (via GH action)
- Increases lipolysis through GH-mediated pathways; promotes lean mass retention
- None. GH effects are anabolic, not appetite-modulating
- Indirect fat loss through GH elevation; best combined with resistance training protocols
- Clenbuterol
- Beta-2 adrenergic agonist. Increases sympathetic nervous system activity
- Cardiac muscle, skeletal muscle, adipose tissue
- Increases metabolic rate and lipolysis through beta-adrenergic signaling
- Variable. Can suppress appetite in some subjects
- Acute thermogenic effects; cardiovascular side effects limit long-term use